Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioMeDent is a biotechnology company focused on developing advanced regenerative solutions for dental and craniofacial applications. The company's core technology is a proprietary Bio-Active Matrix (BAM) platform, which serves as a synthetic scaffold designed to deliver growth factors like Bone Morphogenetic Protein 2 (BMP-2) for localized bone regeneration. Their lead product candidates aim to provide more effective and less invasive alternatives to traditional bone grafting procedures in oral surgery. By combining material science with biological signaling, BioMeDent seeks to improve clinical outcomes for patients requiring alveolar ridge augmentation and periodontal repair.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioMeDent.